A Response to: Letter to the Editor with Regard to the Cost-Effectiveness of an Advanced Hybrid Closed-Loop System in People with Type 1 Diabetes: A Health Economic Analysis in Sweden

被引:0
作者
J. Jendle
M. I. Buompensiere
A. L. Holm
S. de Portu
S. J. P. Malkin
O. Cohen
机构
[1] Örebro University,Institute of Medical Sciences
[2] Medtronic International Trading Sàrl,undefined
[3] Medtronic Denmark,undefined
[4] Ossian Health Economics and Communications,undefined
来源
Diabetes Therapy | 2022年 / 13卷
关键词
Cost-effectiveness; Type 1 diabetes; Sweden; Advanced hybrid closed-loop;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:1125 / 1129
页数:4
相关论文
共 52 条
[11]  
Evans M(2021)Real-world performance of the MiniMed™ 780G system: first report of outcomes from 4120 users Diabetes Technol Ther 58 207-213
[12]  
Welsh Z(2021)Safety and glycemic outcomes during the MiniMed™ advanced hybrid closed-loop system pivotal trial in adolescents and adults with type 1 diabetes Diabetes Technol Ther 15 273-280
[13]  
Ells S(2021)One-year experience of hybrid closed-loop system in children and adolescents with type 1 diabetes previously treated with multiple daily injections: drivers to successful outcomes Acta Diabetol 10 1179551417746957-1158
[14]  
Seibold A(2013)Routine sensor-augmented pump therapy in type 1 diabetes: the INTERPRET study Diabetes Technol Ther 27 1151-undefined
[15]  
Rose L(2017)Evaluation of FreeStyle Libre flash glucose monitoring system on glycemic control, health-related quality of life, and fear of hypoglycemia in patients with type 1 diabetes Clin Med Insights Endocrinol Diabetes undefined undefined-undefined
[16]  
Klausmann G(2010)Fear of hypoglycaemia in adults with type 1 diabetes Diabet Med undefined undefined-undefined
[17]  
Seibold A(undefined)undefined undefined undefined undefined-undefined
[18]  
Visser MM(undefined)undefined undefined undefined undefined-undefined
[19]  
Charleer S(undefined)undefined undefined undefined undefined-undefined
[20]  
Fieuws S(undefined)undefined undefined undefined undefined-undefined